Chairman and CEO David B. Snow Jr. will address the Deutsche Bank 36th Annual Health Care Conference in Boston on Tuesday, May 3, 2011 at 10 a.m. ET at the Intercontinental Boston Hotel. Dr. Robert Epstein, Medco's chief clinical research and development officer, will also attend;
Timothy Wentworth, group president, employer and key accounts, is scheduled to address the Bank of America Merrill Lynch 2011 Health Care Conference in Las Vegas on Tuesday, May 10, 2011 at 8:40 a.m. PT at the Wynn Encore Hotel.
Richard J. Rubino, Medco's chief financial officer, is also scheduled to attend both conferences.
Both presentations may be heard live via a simulcast link and the accompanying slides will be available at www.medco.com/investor. Real Player or Windows Media Player is required to listen to the webcast. Free downloads of both players are available at the webcast site. The webcast will be available for replay for one month following the presentation.
Medco Health Solutions, Inc. (NYSE: MHS) is pioneering the world's most advanced pharmacy® and its clinical research and innovations are part of Medco making medicine smarter™ for approximately 65 million members.
With more than 20,000 employees worldwide dedicated to improving patient health and reducing costs for a wide range of public and private sector clients, and 2010 revenues of $66 billion, Medco ranks 35th on the Fortune 500 list and is named among the world's most innovative, most admired and most trustworthy companies.
This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.